Cargando…
Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation
Purpose: To determine the incidence and risk factors of bleeding events as well as assess the performance of the PRECISE-DAPT score in elderly patients (≥75 years) who underwent percutaneous coronary intervention (PCI) and one-year dual antiplatelet therapy (DAPT). Methods: A total of 940 patients (...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362353/ https://www.ncbi.nlm.nih.gov/pubmed/34393770 http://dx.doi.org/10.3389/fphar.2021.661619 |
_version_ | 1783738145019265024 |
---|---|
author | Qian, Yanxia Xu, Bing Qian, Xiaodong Cao, Lu Cheng, Yujia Liu, Xinjian Bai, Song Han, Zhijun Wang, Junhong |
author_facet | Qian, Yanxia Xu, Bing Qian, Xiaodong Cao, Lu Cheng, Yujia Liu, Xinjian Bai, Song Han, Zhijun Wang, Junhong |
author_sort | Qian, Yanxia |
collection | PubMed |
description | Purpose: To determine the incidence and risk factors of bleeding events as well as assess the performance of the PRECISE-DAPT score in elderly patients (≥75 years) who underwent percutaneous coronary intervention (PCI) and one-year dual antiplatelet therapy (DAPT). Methods: A total of 940 patients (≥75 years) who received PCI and one-year DAPT were retrospectively enrolled into the study. The multivariable logistic regression analysis was conducted to identify risk factors of antiplatelet-related bleeding complications. The receiver operating characteristic (ROC) curve analysis and the Delong test were performed to obtain the optimized PRECISE-DAPT score. Results: It was observed that 89 (9.47%) patients suffered bleeding complications, while 37 (3.94%) of them had the Bleeding Academic Research Consortium (BARC, type ≥2) bleeding events. We stratified the PRECISE-DAPT score in tertiles (T1: ≤23; T2:24 to 32; T3: ≥33) and found that BARC ≥ 2 type bleeding occurred more frequently in T3 than in T1 and T2 (8.25 vs. 1.46% vs. 2.40%, p <0.05). The ROC curve analysis revealed that the PRECISE-DAPT score cutoff for BARC ≥2 type bleeding prediction was 33. In comparison with the current recommended cutoff score of 25 (AUC: 0.608, based on ROC analysis), the Delong test indicated significantly improved ability for predicting BARC ≥ 2 type bleeding events using the proposed cutoff value of 33, AUC of 0.676 (p = 0.03), and Brier Score of 0.04. The multivariable logistic regression analysis demonstrated that the PRECISE-DAPT score ≥ 33 [OR: 3.772; 95% CI (1.229, 11.578); p = 0.02] was associated with BARC ≥ 2 type bleeding event, along with a history of hemorrhagic stroke [OR: 6.806; 95% CI (1.465, 31.613); p = 0.014], peptic ulcer [OR: 3.871; 95% CI (1.378, 10.871); p = 0.01], and/or myocardial infarction [MI, OR: 3.081; 95% CI (1.140, 8.326); p = 0.027]. Conclusion: A higher PRECISE-DAPT score of 33 might be a more reasonable cutoff value for predicting BARC ≥2 type bleeding risk in CAD patients (≥75 years). In addition, the history of hemorrhagic stroke, peptic ulcer, and myocardial infarction were identified as the risk factors of BARC ≥2 type bleeding events. |
format | Online Article Text |
id | pubmed-8362353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83623532021-08-14 Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation Qian, Yanxia Xu, Bing Qian, Xiaodong Cao, Lu Cheng, Yujia Liu, Xinjian Bai, Song Han, Zhijun Wang, Junhong Front Pharmacol Pharmacology Purpose: To determine the incidence and risk factors of bleeding events as well as assess the performance of the PRECISE-DAPT score in elderly patients (≥75 years) who underwent percutaneous coronary intervention (PCI) and one-year dual antiplatelet therapy (DAPT). Methods: A total of 940 patients (≥75 years) who received PCI and one-year DAPT were retrospectively enrolled into the study. The multivariable logistic regression analysis was conducted to identify risk factors of antiplatelet-related bleeding complications. The receiver operating characteristic (ROC) curve analysis and the Delong test were performed to obtain the optimized PRECISE-DAPT score. Results: It was observed that 89 (9.47%) patients suffered bleeding complications, while 37 (3.94%) of them had the Bleeding Academic Research Consortium (BARC, type ≥2) bleeding events. We stratified the PRECISE-DAPT score in tertiles (T1: ≤23; T2:24 to 32; T3: ≥33) and found that BARC ≥ 2 type bleeding occurred more frequently in T3 than in T1 and T2 (8.25 vs. 1.46% vs. 2.40%, p <0.05). The ROC curve analysis revealed that the PRECISE-DAPT score cutoff for BARC ≥2 type bleeding prediction was 33. In comparison with the current recommended cutoff score of 25 (AUC: 0.608, based on ROC analysis), the Delong test indicated significantly improved ability for predicting BARC ≥ 2 type bleeding events using the proposed cutoff value of 33, AUC of 0.676 (p = 0.03), and Brier Score of 0.04. The multivariable logistic regression analysis demonstrated that the PRECISE-DAPT score ≥ 33 [OR: 3.772; 95% CI (1.229, 11.578); p = 0.02] was associated with BARC ≥ 2 type bleeding event, along with a history of hemorrhagic stroke [OR: 6.806; 95% CI (1.465, 31.613); p = 0.014], peptic ulcer [OR: 3.871; 95% CI (1.378, 10.871); p = 0.01], and/or myocardial infarction [MI, OR: 3.081; 95% CI (1.140, 8.326); p = 0.027]. Conclusion: A higher PRECISE-DAPT score of 33 might be a more reasonable cutoff value for predicting BARC ≥2 type bleeding risk in CAD patients (≥75 years). In addition, the history of hemorrhagic stroke, peptic ulcer, and myocardial infarction were identified as the risk factors of BARC ≥2 type bleeding events. Frontiers Media S.A. 2021-07-30 /pmc/articles/PMC8362353/ /pubmed/34393770 http://dx.doi.org/10.3389/fphar.2021.661619 Text en Copyright © 2021 Qian, Xu, Qian, Cao, Cheng, Liu, Bai, Han and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Qian, Yanxia Xu, Bing Qian, Xiaodong Cao, Lu Cheng, Yujia Liu, Xinjian Bai, Song Han, Zhijun Wang, Junhong Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation |
title | Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation |
title_full | Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation |
title_fullStr | Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation |
title_full_unstemmed | Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation |
title_short | Incidence and Risk Factors for Antiplatelet Therapy–Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation |
title_sort | incidence and risk factors for antiplatelet therapy–related bleeding complications among elderly patients after coronary stenting: a multicenter retrospective observation |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362353/ https://www.ncbi.nlm.nih.gov/pubmed/34393770 http://dx.doi.org/10.3389/fphar.2021.661619 |
work_keys_str_mv | AT qianyanxia incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT xubing incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT qianxiaodong incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT caolu incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT chengyujia incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT liuxinjian incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT baisong incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT hanzhijun incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation AT wangjunhong incidenceandriskfactorsforantiplatelettherapyrelatedbleedingcomplicationsamongelderlypatientsaftercoronarystentingamulticenterretrospectiveobservation |